The board of directors of IDEX Biometrics ASA has resolved to issue 1,060,179 ordinary shares at NOK 1.83 per share to employees who participate in the company’s Employee Share Purchase Plan (ESPP), which plan was approved by the annual general meeting on 15 May 2020. 53 employees participated in the ESPP in this period. The participating employees have elected to invest a part of the base salary in ordinary shares in the company. Purchase takes place every three months. The shares are restricted for three months. Following the issue, the Company's share capital will be NOK 137,463,240.15 divided into 916,421,601 shares each with a nominal value of NOK 0.15. Primary insidersCertain primary insiders acquired shares as follows: CEO Vince Graziani acquired 23,093 ordinary shares. After the transaction, Mr. Graziani holds the equivalent of 983,332 ordinary shares and 5,000,000 incentive subscription rights to ordinary shares in IDEX. CFO Derek D’Antilio acquired 51,960 ordinary shares. After the transaction, Mr. D’Antilio holds the equivalent of 847,386 ordinary shares and 2,000,000 incentive subscription rights to ordinary shares in IDEX. CTO Anthony Eaton acquired 2,989 ordinary shares. After the transaction, Mr. Eaton holds 252,564 ordinary shares and 1,452,800 incentive subscription rights to ordinary shares in IDEX. VP Finance Erling Svela acquired 14,606 ordinary shares. After the transaction, Mr. Svela holds 353,465 ordinary shares and 1,061,200 incentive subscription rights to ordinary shares in IDEX. IDEX 2020 ESPPThe ESPP was approved at the annual general meeting on 15 May 2020. Reference is made to the notice of said meeting where the plan document in connection with the ESPP is attached. All employees in the Company and its subsidiaries, except in China, have been offered to subscribe for shares in the Company in connection with the ESPP. The ESPP is structured around four contribution periods a year, each starting on the first day of the calendar month following each planned disclosure of an interim report of the Company and lasts for the following three months. During each contribution period, a fixed amount (up to 20% of the employee’s gross base salary) is withheld from the employee’s net salary. The employee may sign up to participate in the ESPP from the date of a public disclosure of an interim report until the beginning of the contribution period. Unless the employee actively withdraws from the ESPP, participation is automatically renewed for the same amount for subsequent contribution periods. The board's resolution to issue new shares in connection with the ESPP is made pursuant to the authorization granted by the Company's annual general meeting on 15 May 2020 to increase the Company's share capital in connection with the ESPP. In accordance with the ESPP, the subscription price is the lower closing price of the Company’s share, as traded on Oslo Børs, on the first or last day of the contribution period, less 15% discount. Payment of the subscription amount is made out of the relevant employee salary withholding. In accordance with Regulation (EU) 2017/1129 (the “Prospectus Regulation”) Article 1 (5) h, issuance of shares in connection with the ESPP is exempt from the obligation to publish a listing prospectus. For further information contact:Marianne Bøe, Investor Relations E-mail: firstname.lastname@example.orgTel: + 47 918 00186 Derek D’Antilio, Chief Financial OfficerE-mail: email@example.comTel: +1 978 273 1344 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings. We invent, engineer, and commercialize these secure and safe yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity. For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Australian conservationists on Wednesday unveiled plans to build the world's first refuge for the platypus, to promote breeding and rehabilitation as the duck-billed mammal faces extinction due to climate change. The Taronga Conservation Society Australia and the New South Wales State government said they would build the specialist facility, mostly ponds and burrows for the semiaquatic creatures, at a zoo 391 km (243 miles) from Sydney, by 2022, which could house up to 65 platypuses. "There is so much to learn about the platypus and we know so little," Taronga CEO Cameron Kerr told reporters.
The first batch of AstraZeneca’s COVID-19 vaccine has arrived in Taiwan. Taiwan has signed contracts securing 10 million doses of the AstraZeneca vaccine, 5.05 million doses of the Moderna vaccine and 4.76 million doses of vaccines through COVAX. Health care workers, especially those who have direct contact with suspected or confirmed COVID-19 cases, will be the first to get the shots, Taiwan’s Health Minister Chen Shih-chung said at a news briefing.